GI Manifestations With a Focus on the Esophagus: Recent Progress in Understanding Pathogenesis.
GI Manifestations With a Focus on the Esophagus: Recent Progress in Understanding Pathogenesis.
复制标题
DOI:
10.1007/s11926-019-0841-x
复制
发表时间:
2019-07-03
影响因子:
5
通讯作者:
Kahrilas P
中科院分区:
文献类型:
--
作者:
Tétreault MP;Kahrilas P
Esophageal dysfunction is common in systemic sclerosis (SSc) patients. Limited treatment options are available for scleroderma esophageal disease. Here, we discuss recent updates on the diagnosis, treatment, and characterization that have been made in patients with scleroderma esophageal disease. In the past few years, novel diagnostic tools have provided insight into esophageal dysmotility in SSc patients. New drugs are being tested and might improve symptoms and quality of life in SSc patients with esophageal dysfunction. Molecular stratification methods have facilitated the identification of molecular signatures in the esophagus of SSc patients. The Friend leukemia integration 1 (Fli1) conditional knockout mouse is the first animal model to report an esophageal phenotype with SSc features. The clinical presentation in SSc patients with esophageal dysfunction is heterogeneous, complicating diagnosis and management. The improvement of diagnostic tools for esophageal symptoms and dysfunction and the use of molecular approaches in SSc mouse models and patient biopsies offer an opportunity to improve the characterization of SSc esophageal disease, which should help improve management and treatment decisions.
登录
查看更多内容
影响因子:
3.5
作者:
Kimmel JN;Carlson DA;Hinchcliff M;Carns MA;Aren KA;Lee J;Pandolfino JE
通讯作者:
Pandolfino JE
影响因子:
5.5
作者:
Aden, N.;Shiwen, X.;Stratton, R.
通讯作者:
Stratton, R.
影响因子:
4.6
作者:
Asano Y;Bujor AM;Trojanowska M
通讯作者:
Trojanowska M
影响因子:
9.8
作者:
Kessing, Boudewijn F.;Bredenoord, Albert J.;Smout, A. J. P. M.
通讯作者:
Smout, A. J. P. M.
影响因子:
12.6
作者:
Crowell, Michael D.;Umar, Sarah B.;Vela, Marcelo F.
通讯作者:
Vela, Marcelo F.